ATLANTIC CITY, N.J. - A New Jersey judge on Wednesday ordered a $450,000 reduction in a pain and suffering award for an Accutane inflammatory bowel disease (IBD) plaintiff but denied motions for judgment as a matter of law or a new trial in her case and two other cases (In Re: Accutane Litigation, No. 271 MT, Kelly Mace v. Hoffman-La Roche Inc., No. ATL-L-199-05 MT, Lance Sager v. Hoffman-La Roche Inc., No. ATL-L-197-05 MT, Jordan Speisman v. Hoffman-La Roche Inc., No. ATL-L-196-05 MT, N.J. Super., Atlantic Co.; See 11/2/09, Page 11). From Mealey's Emerging Drugs & Devices